CC on NYSE

Chemours

Logo: Unknown author Unknown author, Public domain, via Wikimedia Commons⁴

American chemical company

The Chemours Company (, kem-ORZ), headquartered in Wilmington, Delaware, is an American chemical company. It was spun off from DuPont in July 2015.³ From Wikipedia, CC BY-SA 4.0

Price unavailable

Last updated Oct 18, 2026.

Overview

2015Founded¹

Compare with Huntsman Corporation, Olin Corporation or Solstice Advanced Materials Inc., or pick any stock.

TickerCC on NYSE¹
Industrychemical industry¹
HeadquartersWilmington¹
Websitechemours.com
Legal formDelaware corporation¹
Incorporated inDE⁵
Business address1007 Market Street, Wilmington, De 19801⁵
Filer categoryLarge accelerated filer⁵

See how the biggest companies compare on our leaderboards

The Chemours Company (kem-ORZ), headquartered in Wilmington, Delaware, is an American chemical company. It was spun off from DuPont in July 2015. The company's primary products are refrigerants, titanium dioxide pigment, and industrial fluoropolymer resins. The company operates 28 major production facilities in 8 countries and serves approximately 2,400 customers in approximately 110 countries.³

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

15.5%Gross margin⁸

-6.6%Net margin⁸

0.4%Revenue growth, 2025⁸

-154.4%Return on equity⁸

16.40×Debt to equity⁸

$51.0MFree cash flow⁸

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Business segments

Titanium Technologies brought in 42% of the revenue Chemours broke down this way in fiscal 2025.

Titanium Technologies$2.4B⁸42%down 6% from 2024
Thermal And Specialized Solutions$2.1B⁸36%up 13% from 2024
Advanced Performance Materials$1.3B⁸22%down 5% from 2024
Other Non-Reportable$50.0M⁸1%down 7% from 2024

Business segments by year

Business segments	2023	2024	2025
Titanium Technologies	$2.7B	$2.6B	$2.4B
Thermal And Specialized Solutions	$1.9B	$1.8B	$2.1B
Advanced Performance Materials	$1.5B	$1.3B	$1.3B
Other Non-Reportable	$85.0M	$54.0M	$50.0M

Regions

North America brought in 46% of the revenue Chemours broke down this way in fiscal 2025.

North America$2.7B⁸46%up 3% from 2024
Asia Pacific$1.2B⁸21%down 10% from 2024
EMEA$1.2B⁸20%up 2% from 2024
Latin America$748.0M⁸13%up 12% from 2024

Regions by year

Regions	2023	2024	2025
North America	$2.7B	$2.6B	$2.7B
Asia Pacific	$1.5B	$1.4B	$1.2B
EMEA	$1.2B	$1.1B	$1.2B
Latin America	$674.0M	$669.0M	$748.0M

Where the money goes

Where each dollar of revenue went, fiscal 2025

Cost of revenueSelling, general and admin

Cost of revenue79¢$4.9B
Research and development2¢$108.0M
Selling, general and admin13¢$799.0M
Interest4¢$269.0M
Income tax2¢$109.0M

Out of $5.8B in revenue.⁸ The company lost money this year.

Where each dollar of operating cash went, fiscal 2025

Capital spendingDividends paid

Capital spending73¢$213.0M
Dividends paid27¢$78.0M

Out of $264.0M of cash from operations. Spending exceeded cash from operations; the rest came from savings or borrowing.⁸

Financial statements

Revenue⁹¹⁰¹¹¹²⁸$5.8B in 2025+5% since 2019

Gross profit⁹¹⁰¹¹¹²⁸$902.0M in 2025−15% since 2019

Net income⁹¹⁰¹¹¹²⁸-$386.0M in 2025+642% since 2019

Every line of the income statement as filed: the last 3 fiscal years (annual) or 8 quarters (quarterly), latest first.⁸

Period ending	2025-12-31	2024-12-31	2023-12-31
Net sales	$5.8B	$5.8B	$6.1B
Cost of goods sold	$4.9B	$4.6B	$4.8B
Gross profit	$902.0M	$1.1B	$1.3B
Selling, general, and administrative expense	$799.0M	$598.0M	$1.3B
Research and development expense	$108.0M	$109.0M	$108.0M
Restructuring, asset-related, and other charges	$59.0M	$60.0M	$153.0M
Goodwill impairment charge	$0	$56.0M
Total other operating expenses	$966.0M	$823.0M	$1.5B
Equity in earnings of affiliates	$35.0M	$43.0M	$45.0M
Interest expense, net	-$269.0M	-$263.0M	-$208.0M
Loss on extinguishment of debt	-$5.0M	-$1.0M	-$1.0M
Other income, net	$26.0M	$8.0M	$91.0M
(Loss) Income before income taxes	-$277.0M	$106.0M	-$318.0M
(Benefit from) provision for income taxes	$109.0M	$37.0M	-$66.0M
Net (loss) income	-$386.0M	$69.0M	-$252.0M
Less: Net income attributable to non-controlling interests			$1.0M
Net (loss) income attributable to Chemours	-$386.0M	$69.0M	-$253.0M
Basic (loss) earnings per share of common stock	-$2.57	$0.46	-$1.70
Diluted (loss) earnings per share of common stock	-$2.57	$0.46	-$1.70

Period ending	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
Net sales	$1.3B	$1.5B	$1.6B	$1.4B	$1.4B	$1.5B	$1.6B	$1.4B
Cost of goods sold	$1.2B	$1.3B	$1.3B	$1.1B	$1.1B	$1.2B	$1.2B	$1.1B
Gross profit					$265.0M
Selling, general, and administrative expense		$122.0M	$424.0M
Total other operating expenses		$152.0M	$470.0M
(Loss) Income before income taxes	-$67.0M	$38.0M	-$248.0M		$1.0M	-$32.0M	$69.0M	$70.0M
(Benefit from) provision for income taxes		-$8.0M	$131.0M	$5.0M	$12.0M
Net (loss) income	-$47.0M	$46.0M	-$379.0M	-$5.0M	-$11.0M	-$32.0M	$60.0M	$54.0M
Net (loss) income attributable to Chemours	-$47.0M	$46.0M	-$380.0M	-$5.0M	-$11.0M	-$32.0M	$60.0M	$54.0M
Basic (loss) earnings per share of common stock	-$0.31	$0.31	-$2.53	-$0.03	-$0.08	-$0.22	$0.40	$0.36
Diluted (loss) earnings per share of common stock	-$0.31	$0.31	-$2.53	-$0.03	-$0.08	-$0.22	$0.39	$0.36

Total assets⁹¹⁰¹¹¹²⁸$7.4B in 2025+2% since 2019

Total liabilities¹⁵⁹¹⁰¹¹⁸$7.1B in 2025+9% since 2019

Shareholders’ equity¹⁵⁹¹⁰¹¹⁸$250.0M in 2025−64% since 2019

Cash¹⁵⁹¹¹¹²⁸$670.0M in 2025−29% since 2019

Long-term debt¹⁵⁹¹⁰¹¹⁸$4.1B in 2025+2% since 2019

Every line of the balance sheet as filed: the last 5 fiscal years (annual) or 7 quarters (quarterly), latest first.⁸

Period ending	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Cash and cash equivalents	$670.0M				$713.0M
Restricted cash and restricted cash equivalents	$2.0M
Accounts and notes receivable, net	$679.0M				$770.0M
Inventories	$1.6B				$1.5B
Prepaid expenses and other	$80.0M				$71.0M
Assets held for sale	$1.0M
Total current assets	$3.0B				$3.0B
Property, plant, and equipment	$9.9B	$9.8B	$9.8B	$9.6B	$9.6B
Less: Accumulated depreciation	-$6.8B				-$6.4B
Property, plant, and equipment, net	$3.1B	$3.1B	$3.1B	$3.1B	$3.2B
Operating lease right-of-use assets	$271.0M	$273.0M	$275.0M	$281.0M	$265.0M
Goodwill	$46.0M				$46.0M
Other intangible assets, net	$2.0M				$3.0M
Investments in affiliates	$160.0M				$152.0M
Assets held for sale, non-current	$21.0M
Restricted cash and restricted cash equivalents	$52.0M				$50.0M
Other assets	$751.0M	$690.0M	$684.0M	$764.0M	$788.0M
Total assets	$7.4B	$7.5B	$7.5B	$7.4B	$7.5B
Accounts payable	$954.0M				$1.2B
Compensation and other employee-related cost	$96.0M				$99.0M
Short-term and current maturities of long-term debt	$42.0M				$54.0M
Current environmental remediation	$88.0M				$115.0M
Other accrued liabilities	$506.0M	$580.0M	$585.0M	$396.0M	$396.0M
Total current liabilities	$1.7B	$1.9B	$1.8B	$1.7B	$1.8B
Long-term debt, net	$4.1B	$4.1B	$4.1B	$4.1B	$4.1B
Operating lease liabilities	$191.0M	$197.0M	$201.0M	$208.0M	$198.0M
Long-term environmental remediation	$530.0M				$456.0M
Deferred income taxes	$37.0M	$27.0M	$28.0M		$35.0M
Other liabilities	$588.0M				$369.0M
Total liabilities	$7.1B		$7.2B	$6.8B	$6.9B
Common stock (par value $0.01 per share; 810,000,000 shares authorized; 198,720,786 shares issued and 149,893,993 shares outstanding at December 31, 2025; 198,300,033 shares issued and 149,428,431 shares outstanding at December 31, 2024)	$2.0M				$2.0M
Treasury stock, at cost (48,826,793 shares at December 31, 2025; 48,871,602 shares at December 31, 2024)	-$1.8B				-$1.8B
Additional paid-in capital	$1.1B				$1.1B
Retained earnings	$1.2B	$1.3B	$1.2B	$1.6B	$1.7B
Accumulated other comprehensive loss	-$244.0M	-$278.0M	-$286.0M	-$334.0M	-$367.0M
Total Chemours stockholders equity	$250.0M	$274.0M	$228.0M	$566.0M	$571.0M
Non-controlling interests	$1.0M				$1.0M
Total equity	$251.0M	$276.0M	$230.0M	$567.0M	$572.0M
Total liabilities and equity	$7.4B	$7.5B	$7.5B	$7.4B	$7.5B
Common stock , par value (USD per share)	$0.01				$0.01
Common stock, shares authorized (in shares)	810.0M shares				810.0M shares
Common stock, shares Issued (in shares)	198.7M shares				198.3M shares
Common stock, shares outstanding (in shares)	149.9M shares				149.4M shares
Treasury stock (in shares)	48.8M shares				48.9M shares

Period ending	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2023-12-31	2022-12-31
Cash and cash equivalents	$670.0M				$713.0M	$1.2B
Restricted cash and restricted cash equivalents	$2.0M
Accounts and notes receivable, net	$679.0M				$770.0M	$622.0M
Inventories	$1.6B				$1.5B	$1.3B
Prepaid expenses and other	$80.0M				$71.0M
Assets held for sale	$1.0M
Total current assets	$3.0B				$3.0B	$3.8B
Property, plant, and equipment	$9.9B	$9.8B	$9.8B	$9.6B	$9.6B
Less: Accumulated depreciation	-$6.8B				-$6.4B	-$6.2B
Property, plant, and equipment, net	$3.1B	$3.1B	$3.1B	$3.1B	$3.2B	$3.2B
Operating lease right-of-use assets	$271.0M	$273.0M	$275.0M	$281.0M	$265.0M	$263.0M
Goodwill	$46.0M				$46.0M
Other intangible assets, net	$2.0M				$3.0M
Investments in affiliates	$160.0M				$152.0M	$158.0M	$175.0M
Assets held for sale, non-current	$21.0M
Restricted cash and restricted cash equivalents	$52.0M				$50.0M
Other assets	$751.0M	$690.0M	$684.0M	$764.0M	$788.0M	$664.0M
Total assets	$7.4B	$7.5B	$7.5B	$7.4B	$7.5B	$8.2B
Accounts payable	$954.0M				$1.2B
Compensation and other employee-related cost	$96.0M				$99.0M
Short-term and current maturities of long-term debt	$42.0M				$54.0M
Current environmental remediation	$88.0M				$115.0M
Other accrued liabilities	$506.0M	$580.0M	$585.0M	$396.0M	$396.0M	$1.1B
Total current liabilities	$1.7B	$1.9B	$1.8B	$1.7B	$1.8B	$2.5B
Long-term debt, net	$4.1B	$4.1B	$4.1B	$4.1B	$4.1B	$4.0B
Operating lease liabilities	$191.0M	$197.0M	$201.0M	$208.0M	$198.0M	$208.0M
Long-term environmental remediation	$530.0M				$456.0M
Deferred income taxes	$37.0M	$27.0M	$28.0M		$35.0M
Other liabilities	$588.0M				$369.0M	$329.0M
Total liabilities	$7.1B		$7.2B	$6.8B	$6.9B	$7.5B
Common stock (par value $0.01 per share; 810,000,000 shares authorized; 198,720,786 shares issued and 149,893,993 shares outstanding at December 31, 2025; 198,300,033 shares issued and 149,428,431 shares outstanding at December 31, 2024)	$2.0M				$2.0M
Treasury stock, at cost (48,826,793 shares at December 31, 2025; 48,871,602 shares at December 31, 2024)	-$1.8B				-$1.8B
Additional paid-in capital	$1.1B				$1.1B
Retained earnings	$1.2B	$1.3B	$1.2B	$1.6B	$1.7B
Accumulated other comprehensive loss	-$244.0M	-$278.0M	-$286.0M	-$334.0M	-$367.0M
Total Chemours stockholders equity	$250.0M	$274.0M	$228.0M	$566.0M	$571.0M	$721.0M
Non-controlling interests	$1.0M				$1.0M
Total equity	$251.0M	$276.0M	$230.0M	$567.0M	$572.0M	$723.0M	$1.1B
Total liabilities and equity	$7.4B	$7.5B	$7.5B	$7.4B	$7.5B	$8.2B
Common stock , par value (USD per share)	$0.01				$0.01
Common stock, shares authorized (in shares)	810.0M shares				810.0M shares
Common stock, shares Issued (in shares)	198.7M shares				198.3M shares
Common stock, shares outstanding (in shares)	149.9M shares				149.4M shares
Treasury stock (in shares)	48.8M shares				48.9M shares

Cash from operations⁹¹⁰¹¹¹²⁸$264.0M in 2025−59% since 2019

Capital spending⁹¹⁰¹¹¹²⁸$213.0M in 2025−56% since 2019

Free cash flow⁹¹⁰¹¹¹²⁸$51.0M in 2025−70% since 2019

Dividends paid¹⁶¹⁰¹¹¹²⁸$78.0M in 2025−52% since 2019

Share buybacks⁹¹⁰¹¹¹²⁸$69.0M in 2023−79% since 2019

Every line of the cash flow as filed: the last 3 fiscal years, latest first.⁸

Period ending	2025-12-31	2024-12-31	2023-12-31
Net (loss) income	-$386.0M	$69.0M	-$252.0M
Depreciation and amortization	$340.0M	$292.0M	$309.0M
Gain on sales of assets and businesses, net	-$8.0M	-$3.0M	-$110.0M
Equity in earnings of affiliates, net	-$7.0M	-$1.0M	$11.0M
Loss (gain) on extinguishment of debt	$5.0M	$1.0M	$1.0M
Amortization of debt issuance costs and issue discounts	$11.0M	$12.0M	$9.0M
Deferred tax provision (benefit)	$64.0M	-$31.0M	-$143.0M
Asset-related charges	$32.0M	$27.0M	$95.0M
Stock-based compensation expense	$21.0M	$15.0M	$18.0M
Net periodic pension (income) cost	-$2.0M	$6.0M	$9.0M
Defined benefit plan contributions	-$2.0M	-$12.0M	-$10.0M
Other operating charges and credits, net	$18.0M	-$42.0M	$1.0M
Goodwill impairments	$0	$56.0M
Accounts and notes receivable, net	$106.0M	-$139.0M	-$14.0M
Inventories and other current operating assets	-$106.0M	-$140.0M	$61.0M
Other non-current operating assets	$66.0M	-$98.0M
Accounts payable	-$165.0M	$4.0M	-$74.0M
Other current operating liabilities	-$3.0M	-$660.0M	$642.0M
Non-current operating liabilities	$280.0M	$11.0M	$3.0M
Cash provided by (used for) operating activities	$264.0M	-$633.0M	$556.0M
Purchases of property, plant, and equipment	-$213.0M	-$360.0M	-$370.0M
Proceeds from sales of assets and businesses, net of cash divested	$7.0M	$3.0M	$143.0M
Foreign exchange contract settlements, net	-$1.0M	$2.0M	-$8.0M
Other investing activities	$1.0M	$2.0M	$6.0M
Cash used for investing activities	-$206.0M	-$353.0M	-$229.0M
Proceeds from issuance of debt, net	$748.0M	$606.0M	$648.0M
Debt repayments	-$787.0M	-$490.0M	-$280.0M
Payments of debt issuance costs	-$7.0M	-$9.0M	-$4.0M
Payments on finance leases	-$14.0M	-$12.0M	-$11.0M
Proceeds from supplier financing programs	$80.0M	$93.0M	$123.0M
Payments to supplier financing program	-$88.0M	-$102.0M	-$87.0M
Purchases of treasury stock, at cost			-$69.0M
Proceeds from exercised stock options		$9.0M	$19.0M
Payments related to tax withheld on vested stock awards	-$1.0M	-$3.0M	-$19.0M
Payments of dividends to the Company's common shareholders	-$78.0M	-$148.0M	-$149.0M
(Distributions to) cash received from non-controlling interest shareholders		-$1.0M	$1.0M
Other financing activities	$21.0M	$21.0M
Cash (used for) provided by financing activities	-$126.0M	-$36.0M	$172.0M
Effect of exchange rate changes on cash, cash equivalents, restricted cash and restricted cash equivalents	$29.0M	-$22.0M	$4.0M
(Decrease) increase in cash, cash equivalents, restricted cash and restricted cash equivalents	-$39.0M	-$1.0B	$503.0M
Interest, net of amounts capitalized	$251.0M	$267.0M	$223.0M
Income taxes, net of refunds	$74.0M	$82.0M	$63.0M
Purchases of property, plant, and equipment included in accounts payable	$33.0M	$88.0M	$82.0M

Compare Chemours with another company

The story

On July 1, 2015, DuPont completed the corporate spin-off of Chemours, which began trading on the New York Stock Exchange.

Chemours assumed various liabilities arising from lawsuits against DuPont.

In February 2024, CEO Mark Newman, CFO Jonathan Lock, and Financial Controller Camela Wisel were placed on administrative leave by the board of directors due to delayed payments to some vendors to increase their bonuses, in violation of the company's standards for ethics.

From Wikipedia’s article on Chemours, shared under CC BY-SA 4.0.⁶

Leadership

Who has led Chemours, and when. Pick a name to see everywhere that person has worked.

Chief executive

President

Chief financial officer

20202025

Chief executive officerDenise Dignam Mar 5, 2024 to now¹⁷
Chief executive officerMark P. Vergnano Jun 17, 2015 to Mar 3, 2021¹⁸
PresidentJoseph T. Martinko Aug 2, 2023 to Aug 5, 2024¹⁹
PresidentAlisha Bellezza Mar 1, 2021 to Mar 10, 2023²⁰
PresidentDenise Dignam Mar 1, 2021 to Aug 2, 2023²¹
PresidentEdwin C. Sparks Apr 10, 2018 to Mar 10, 2023²²
PresidentPaul Kirsch Jun 24, 2016 to Mar 6, 2019²³
PresidentMichael P. Heffernan Jun 17, 2015 to Jun 17, 2015²⁴
PresidentE. Bryan Snell Jul 6, 2015 to Mar 3, 2021²⁵
PresidentMark P. Vergnano Jul 6, 2015 to Mar 3, 2021²⁶
PresidentThierry Fj Vanlancker Jul 6, 2015 to Mar 3, 2016²⁷
PresidentChristian W. Siemer Sep 10, 2015 to Feb 6, 2018²⁸
Chief financial officerMatthew S. Abbott Mar 5, 2024 to May 10, 2024²⁹
Chief financial officerShane Hostetter Jul 2, 2024 to now³⁰
Chief financial officerSameer Ralhan Jun 5, 2019 to Mar 10, 2023³¹

Board members and other officers (44)

OfficerDamian Gumpel Mar 4, 2025 to now³²
OfficerJoseph T. Martinko Mar 4, 2025 to now³³
Interim Pres. - Titanium TechDiane I. Picho Mar 29, 2024 to now³⁴
Chief Accounting OfficerDavid Will Aug 13, 2024 to now³⁵
Pres Advanced Performance MatCalderon Gerardo Familiar Apr 4, 2023 to now³⁶
SVP, President, Titanium TechnDenise Dignam Aug 3, 2023 to now³⁷
Senior Vice President, PeopleRon Christopher Charles Oct 3, 2023 to May 10, 2024³⁸
SVP, GC & Corp. SecretaryKristine M. Wellman Oct 7, 2022 to now³⁹
VP, CAO & ControllerCamela Wisel Oct 1, 2021 to Aug 3, 2023⁴⁰
SVP, Chief Development OfficerJonathan Lock Nov 10, 2021 to Aug 3, 2023⁴¹
SVP Corp Communications & CBOAlvenia Scarborough Oct 2, 2020 to now⁴²
VP, CAO & ControllerMatthew S. Abbott Aug 22, 2019 to Aug 5, 2024⁴³
Senior VP of Human ResourcesSusan M. Kelliher Jun 5, 2017 to Mar 10, 2023⁴⁴
Pres Fluoroproducts(Designate)Paul Kirsch Jun 3, 2016 to Jun 3, 2016⁴⁵
Controller (Designate)Amy Trojanowski Jun 17, 2015 to Mar 15, 2019⁴⁶
Pres Chem Solution (Designate)Christian W. Siemer Jun 17, 2015 to Mar 3, 2016⁴⁷
GC and Corp. Sec. (Designate)David C. Shelton Jun 17, 2015 to May 9, 2022⁴⁸
Pres Titanium Tech (Designate)E. Bryan Snell Jun 17, 2015 to Jun 17, 2015⁴⁹
Sr. VP - HR (Designate)Elizabeth Albright Jun 17, 2015 to Mar 10, 2017⁵⁰
VP Corp Comm & CBO (Desginate)Erich Parker Jun 17, 2015 to Mar 4, 2020⁵¹
VP & Asst. TreasurerNigel Pond Jun 17, 2015 to Jun 17, 2015⁵²
Vice PresidentSteven Zelac Jun 17, 2015 to Jun 17, 2015⁵³
Pres Fluoroproduct (Designate)Thierry Fj Vanlancker Jun 17, 2015 to Jun 17, 2015⁵⁴
Board memberJoseph Daniel Kava Jan 13, 2025 to now⁵⁵
Board memberLeslie M. Turner Feb 19, 2025 to now⁵⁶
Board memberCourtney Mather Apr 24, 2025 to now⁵⁷
Board memberGeorge R. Brokaw Apr 24, 2025 to now⁵⁸
Board memberDenise Dignam Mar 29, 2024 to now⁵⁹
Board memberLivingston Satterthwaite Jun 20, 2024 to now⁶⁰
Board memberAlister Cowan Dec 4, 2023 to now⁶¹
Board memberSandra L. Phillips Oct 1, 2021 to Jan 3, 2024⁶²
Board memberErin N. Kane Jun 27, 2019 to now⁶³
Board memberSean D. Keohane May 4, 2018 to now⁶⁴
Board memberMichael P. Heffernan Jun 17, 2015 to Jun 17, 2015²⁴
Board memberNigel Pond Jun 17, 2015 to Jun 17, 2015⁵²
Board memberSteven Zelac Jun 17, 2015 to Jun 17, 2015⁵³
Board memberCurtis J. Crawford Jun 19, 2015 to Apr 28, 2023⁶⁵
Board memberBradley J. Bell Jul 1, 2015 to Apr 29, 2022⁶⁶
Board memberCurt Anastasio Jul 1, 2015 to Aug 7, 2024⁶⁷
Board memberDawn L. Farrell Jul 1, 2015 to now⁶⁸
Board memberMary B. Cranston Jul 1, 2015 to now⁶⁹
Board memberRichard H. Brown Jul 1, 2015 to Apr 30, 2021⁷⁰
Board memberStephen D. Newlin Jul 1, 2015 to Apr 28, 2017⁷¹
Board memberMark P. Vergnano Jul 6, 2015 to Mar 3, 2022²⁶

Former names

Chemours Company, LLCDec 18, 2014 to Apr 21, 2015⁵

Controversies and legal

Legal and regulatory issues

Chemours' plant in Bladen County, North Carolina, was found to be dumping vast quantities of a chemical dubbed "GenX", a precursor of Teflon, into the Cape Fear River. This story is recounted in the 2018 documentary film The Devil We Know, which centers on Parkersburg, West Virginia, where the DuPont facility that manufactured Teflon was located. The documentary follows the personal stories and tribulations of several people who worked at the Parkersburg facility.

In September 2023, a court in the Netherlands found Chemours to be liable for pollution caused by the polytetrafluoroethylene (Teflon) producing plant in Dordrecht, South Holland. The court stated that Chemours' predecessor DuPont had willingly withheld crucial information between 1984 and 1998 about the harmful effects of the substances it used and emitted, which made the pollution unlawful.

PFAS-related settlements: Washington Works, Chambers Works, and other drinking water contamination

Over the course of a century, DuPont was alleged to have dumped 100 million pounds of toxic chemicals into waterways in New Jersey and Delaware from its Chambers Works plant near Carneys Point Township, New Jersey. The property was transferred to Chemours in the corporate spin-off in July 2015. In 2016, Carneys Point Township, New Jersey initiated a $1.1 billion lawsuit against DuPont and Chemours, accusing DuPont of completing the corporate spin-off of Chambers Works into Chemours without first remediating the property as required by law.

In July 2021, Chemours, along with Corteva and DuPont, agreed to a $50 million settlement with Delaware. Chemours's share of the settlement was 50%.

In June 2023, Chemours, along with Corteva and DuPont, agreed to pay $1.2 billion in a national settlement to resolve all PFAS-related drinking water claims. Chemours's share of the settlement was 50%.

In November 2023, Chemours, along with Corteva and DuPont, agreed to a $110 million settlement with Ohio regarding PFAS-related claims, primarily from Washington Works. Chemours's share of the settlement was 50%.

Read the full text

In August 2025, Chemours, along with Corteva and DuPont, agreed to a $2 billion settlement with New Jersey to clean up 4 sites in New Jersey, including 2 industrial sites that discharged PFAS: Parlin and Chambers Works, as well as a shuttered munitions production plant in Pompton Lakes, New Jersey, and a facility that manufactured dynamite in Parlin, New Jersey. The settlement includes an $875 million payment to New Jersey and establishment of a $1.2 billion fund to clean up the 4 sites. Chemours's share of the settlement was 50%.

From Wikipedia’s article on Chemours, shared under CC BY-SA 4.0.⁶

Timeline

Mar 5, 2024New chief executive Denise Dignam becomes CEO¹⁷
Jun 17, 2015New chief executive Mark P. Vergnano becomes CEO¹⁸
2015Founded Founded¹

Filings

438 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 89 major events, 250 insider forms, 28 large holders, 51 other. The latest 20:

Oct 1, 20264 EDGAR
Sep 10, 20268-K EDGAR
Sep 9, 20268-K EDGAR
Aug 13, 20264 EDGAR
Aug 13, 20264 EDGAR
Aug 13, 20264 EDGAR
Aug 11, 20264 EDGAR
Aug 11, 20264 EDGAR
Aug 11, 20264 EDGAR
Aug 11, 20264 EDGAR
Aug 10, 20264 EDGAR
Aug 10, 20264 EDGAR
Aug 5, 202610-Q EDGAR
Aug 4, 20268-K EDGAR
Aug 4, 20264 EDGAR
Aug 4, 20264 EDGAR
Aug 4, 20264 EDGAR
Aug 4, 20264 EDGAR
Jul 1, 20264 EDGAR
Jun 24, 20268-K EDGAR

The 438 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last three years, summarized. The full record is on SEC EDGAR.

Insider trades and holders

Large holders

Investors who own more than 5% must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively. 28 such filings since October 2021, the latest 10:

From Forms 4 and Schedules 13D and 13G filed with the SEC.

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.

Fund	Shares	Value	Share of the fund	Change
BlackRock, Inc.	23,283,074	$477.8M	0.0%	+897,224
Vanguard Portfolio Management LLC	10,568,867	$216.9M	0.0%	+243,526
Vanguard Capital Management LLC	6,784,588	$139.2M	0.0%	+10,671
State Street Corp	6,115,375	$125.5M	0.0%	−7,713
Ameriprise Financial Inc	4,924,004	$101.0M	0.0%	+86,201
American Century Companies Inc	4,379,525	$89.9M	0.0%	−36,339
Jpmorgan Chase & Co	4,199,395	$85.2M	0.0%	+398,522
Geode Capital Management, LLC	3,823,361	$78.5M	0.0%	+219,440
Voya Investment Management LLC	3,544,702	$72.7M	0.1%	+3,502,649
Wolf Hill Capital Management, LP	2,909,262	$59.7M	5.8%	−780,532
D. E. Shaw & Co., Inc.	2,870,039	$58.9M	0.0%	+19,029
Dimensional Fund Advisors LP	2,771,370	$56.9M	0.0%	+537,080
Highland Peak Capital, LLC	2,641,589	$54.2M	15.8%	+1,183,210
UBS Group AG	2,593,745	$53.2M	0.0%	−174,061
Goldman Sachs Group Inc	2,552,439	$52.4M	0.0%	−461,675
Charles Schwab Investment Management Inc	2,044,387	$42.0M	0.0%	−109,262
Vision One Management Partners, LP	1,720,189	$35.3M	12.7%	No change
Northern Trust Corp	1,657,540	$34.0M	0.0%	+91,715
Morgan Stanley	1,641,305	$33.7M	0.0%	−162,397
Nuveen, LLC	1,633,838	$33.5M	0.0%	+1,270,368
Bank of New York Mellon Corp	1,625,379	$33.4M	0.0%	+15,081
Legal & General Group Plc	1,384,024	$28.4M	0.0%	−710,833
Two Sigma Investments, LP	1,362,389	$28.0M	0.0%	+367,686
Marshall Wace, Llp	1,191,775	$24.5M	0.0%	−61,508
Vanguard Fiduciary Trust Co	1,086,496	$22.3M	0.0%	+43,180

13F reports cover disclosed long positions in U.S. stocks only.

Members of Congress who traded it

3 trades disclosed by members of Congress. “Vs S&P since” is the stock’s change since the trade minus the S&P 500’s.

Date	Member	Trade	Amount	Vs S&P since	Filing
Aug 9, 2023	Michael C. Burgess, House	Buy	$15,001 - $50,000	−137.4%	Report
Jul 6, 2023	Michael C. Burgess, House	Buy	$15,001 - $50,000	−140.1%	Report
Jul 6, 2023	Michael C. Burgess, House	Partial sale	$1,001 - $15,000	+140.1%	Report

Members report amounts as ranges, not exact figures. Returns are price-only (no dividends).

Sources

The numbers on this page point here. Each one links to the record it came from.

1
WikidataChemours on Wikidata
2
SEC EDGARChemours filings on SEC EDGAR
3
WikipediaChemours on Wikipedia
4
Wikimedia CommonsChemours logo by Unknown author Unknown author, Public domain
5
SEC EDGARChemours filings on SEC EDGAR
6
WikipediaChemours on Wikipedia (revision used)
7
Wikimedia CommonsChemours photo by Suyash.dwivedi, CC BY-SA 4.0
8
SEC EDGARChemours 10-K for fiscal 2025
9
SEC EDGARChemours 10-K for fiscal 2019
10
SEC EDGARChemours 10-K for fiscal 2020
11
SEC EDGARChemours 10-K for fiscal 2021
12
SEC EDGARChemours 10-K for fiscal 2022
13
SEC EDGARChemours 10-Q for fiscal 2026
14
SEC EDGARChemours 10-Q for fiscal 2026
15
SEC EDGARChemours 10-K for fiscal 2019
16
SEC EDGARChemours 10-K for fiscal 2019
17
SEC EDGARDenise Dignam, Chief executive officer
18
SEC EDGARMark P. Vergnano, Chief executive officer
19
SEC EDGARJoseph T. Martinko, President
20
SEC EDGARAlisha Bellezza, President
21
SEC EDGARDenise Dignam, President
22
SEC EDGAREdwin C. Sparks, President
23
SEC EDGARPaul Kirsch, President
24
SEC EDGARMichael P. Heffernan, President
25
SEC EDGARE. Bryan Snell, President
26
SEC EDGARMark P. Vergnano, President
27
SEC EDGARThierry Fj Vanlancker, President
28
SEC EDGARChristian W. Siemer, President
29
SEC EDGARMatthew S. Abbott, Chief financial officer
30
SEC EDGARShane Hostetter, Chief financial officer
31
SEC EDGARSameer Ralhan, Chief financial officer
32
SEC EDGARDamian Gumpel, Officer
33
SEC EDGARJoseph T. Martinko, Officer
34
SEC EDGARDiane I. Picho, Interim Pres. - Titanium Tech
35
SEC EDGARDavid Will, Chief Accounting Officer
36
SEC EDGARCalderon Gerardo Familiar, Pres Advanced Performance Mat
37
SEC EDGARDenise Dignam, SVP, President, Titanium Techn
38
SEC EDGARRon Christopher Charles, Senior Vice President, People
39
SEC EDGARKristine M. Wellman, SVP, GC & Corp. Secretary
40
SEC EDGARCamela Wisel, VP, CAO & Controller
41
SEC EDGARJonathan Lock, SVP, Chief Development Officer
42
SEC EDGARAlvenia Scarborough, SVP Corp Communications & CBO
43
SEC EDGARMatthew S. Abbott, VP, CAO & Controller
44
SEC EDGARSusan M. Kelliher, Senior VP of Human Resources
45
SEC EDGARPaul Kirsch, Pres Fluoroproducts(Designate)
46
SEC EDGARAmy Trojanowski, Controller (Designate)
47
SEC EDGARChristian W. Siemer, Pres Chem Solution (Designate)
48
SEC EDGARDavid C. Shelton, GC and Corp. Sec. (Designate)
49
SEC EDGARE. Bryan Snell, Pres Titanium Tech (Designate)
50
SEC EDGARElizabeth Albright, Sr. VP - HR (Designate)
51
SEC EDGARErich Parker, VP Corp Comm & CBO (Desginate)
52
SEC EDGARNigel Pond, VP & Asst. Treasurer
53
SEC EDGARSteven Zelac, Vice President
54
SEC EDGARThierry Fj Vanlancker, Pres Fluoroproduct (Designate)
55
SEC EDGARJoseph Daniel Kava, Board member
56
SEC EDGARLeslie M. Turner, Board member
57
SEC EDGARCourtney Mather, Board member
58
SEC EDGARGeorge R. Brokaw, Board member
59
SEC EDGARDenise Dignam, Board member
60
SEC EDGARLivingston Satterthwaite, Board member
61
SEC EDGARAlister Cowan, Board member
62
SEC EDGARSandra L. Phillips, Board member
63
SEC EDGARErin N. Kane, Board member
64
SEC EDGARSean D. Keohane, Board member
65
SEC EDGARCurtis J. Crawford, Board member
66
SEC EDGARBradley J. Bell, Board member
67
SEC EDGARCurt Anastasio, Board member
68
SEC EDGARDawn L. Farrell, Board member
69
SEC EDGARMary B. Cranston, Board member
70
SEC EDGARRichard H. Brown, Board member
71
SEC EDGARStephen D. Newlin, Board member